Brian Carr - Concepedia

Author

Brian Carr

United States Military Academy

Also Known As

B A Carr, B Carr, B. A. Carr, B.A. Carr, BRIAN A. CARR, Brian A. Carr, Brian Carr

Publications

917

Citations

H-Index

Concepts

All Affiliations

United States Military Academy University of Utah Gilead Sciences (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)Medical College of Wisconsin

About

Brian Carr is an author at United States Military Academy specializing in medicine, pharmacology, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	248
2	Engineering	4	4	107
3	Biomedical Engineering	4	4	107
4	Natural Sciences	2	2	63
5	Biochemistry	2	2	56

Brian Carr

Publications

842

Citations

H-Index

Page 1

	Year	Citations
Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins Susan V. Peña, Dan Hanson, Brian Carr, The Journal of Immunology	1997	253
Comparison of Immortalized Fa2N-4 Cells and Human Hepatocytes as in Vitro Models for Cytochrome P450 Induction Niresh Hariparsad, Brian Carr, Raymond Evers, Drug Metabolism and Disposition	2008	87
PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy Elena Bekerman, Joseph Hesselgesser, Brian Carr, Antimicrobial Agents and Chemotherapy Persistent Viral ReservoirAntiretroviral TherapyPd-1 BlockadeHuman RetrovirusImmunology	2019	59
Characterization of the Rhesus Monkey CYP3A64 Enzyme: Species Comparisons of CYP3A Substrate Specificity and Kinetics Using Baculovirus-Expressed Recombinant Enzymes Brian Carr, Ryan Norcross, Yulin Fang, Drug Metabolism and Disposition	2006	57
Characterization of the Human Lung CYP2F1 Gene and Identification of a Novel Lung-specific Binding Motif Brian Carr, Jie Wan, Ronald N. Hines, Journal of Biological Chemistry Transcriptional RegulationInflammatory Lung DiseaseLung InflammationNatural SciencesRespiratory Toxicology	2003	46
Endosomolytic Bioreducible Poly(amido amine disulfide) Polymer Conjugates for the <i>in Vivo</i> Systemic Delivery of siRNA Therapeutics Rubina Parmar, Marina Busuek, Eileen S. Walsh, Bioconjugate Chemistry EngineeringSirna TherapeuticsSirna Delivery VehiclesGene DeliveryBiomedical Engineering	2013	39
Selective Inhibition of Dog Hepatic CYP2B11 and CYP3A12 Ping Lü, Suresh B. Singh, Brian Carr, Journal of Pharmacology and Experimental Therapeutics	2005	35
In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies Thomayant Prueksaritanont, Yuhsin Kuo, Cuyue Tang, Drug Metabolism and Disposition	2006	33
HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys Brian Moldt, Abishek Chandrashekar, Erica N. Borducchi, PLoS Pathogens Persistent Viral ReservoirViral PersistenceViral ReservoirHuman RetrovirusImmunology	2022	31
Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates Stephanie E. Barrett, Rob S. Burke, Marc Abrams, Journal of Controlled Release Cell-based Drug DeliveryNanomedicineEngineeringPolymer-drug ConjugateNano-drug Delivery	2014	30

Page 1